Rare byproduct of marine bacteria kills cancer cells by snipping their DNA

May 12, 2014 by Eric Gershon
Electron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer Institute

(Phys.org) —Yale University researchers have determined how a scarce molecule produced by marine bacteria can kill cancer cells, paving the way for the development of new, low-dose chemotherapies.

The molecule, lomaiviticin A, was previously shown to be lethal to cultured human cancer cells, but the mechanism of its operation remained unsolved for well over a decade. In a series of experiments, Yale scientists Seth Herzon, Peter Glazer, and colleagues show that the molecule nicks, cleaves, and ultimately destroys cancer cells' DNA, preventing replication.

"DNA is one of the primary targets of , and cleavage of both DNA chains is the most potent form of DNA damage," said Herzon, professor of chemistry. "But few anticancer agents are able to directly cleave DNA. The discovery that lomaiviticin A is capable of this suggests it could be very useful as a novel chemotherapy, possibly at low doses."

Results were published May 11 in the journal Nature Chemistry.

Herzon's team tested and distinguished the effects of lomaiviticin A—which is produced by a marine bacterium associated with sea squirts—and two closely related molecules, lomaiviticin C and kinamycin C, which are also produced by bacteria.

All three molecules contain at least one diazofluorene, a particular arrangement of atoms known as a functional group. Lomaiviticin A contains two diazofluorenes, while lomaiviticin C and kinamycin C contain just one. The scientists evaluated and contrasted their effects on ' growth and DNA.

They found that the two diazofluorenes of lomaiviticin A are intimately involved in DNA cleavage, and that the loss of one diazofluorene profoundly diminishes the ability of the molecules to kill cells, Herzon said. Lomaiviticin C or kinamycin C – which have only one diazofluorene – are unable to cleave DNA, and are much less toxic to the cells.

"Our data support a model for DNA cleavage involving breakage of both strands of DNA by a single molecule of lomaiviticin," he said. "The best way to think about this is as if lomaiviticin A were a garden shear and the two strands of DNA were the vines you are trimming. As you would grasp the vines and cut two of them to the same length, lomaiviticin A interacts with DNA and then snips the strands at the same site."

Herzon says that researchers still do not know much about the nature of the interaction of lomaiviticin A with DNA, or the specific sequence of events that leads to DNA breaks.

What is clear, Herzon said, is that "lomaiviticin A possesses powerful DNA–damaging properties."

He added: "I have spent the last six years thinking about these molecules, and could not have predicted this activity, or the remarkable differences between lomaiviticins A and C.  This work highlights the immense power of interdisciplinary studies in synthetic chemistry and molecular biology to address problems that cannot be solved by either field alone."

The paper is titled "The cytotoxicity of (—)-lomaiviticin A arises from induction of double-strand breaks in DNA."

Explore further: Scientists synthesize long-sought-after anticancer agent

More information: "The Cytotoxicity of (–)-Lomaiviticin A Arises From Induction of Double-strand Breaks in DNA." Laureen C. Colis, Christina M. Woo, Denise C. Hegan, Zhenwu Li, Peter M. Glazer and Seth B. Herzon Nat. Chem. 2014, 6, Advance Online Publiction, DOI: 10.1038/nchem.1944

Related Stories

Scientists synthesize long-sought-after anticancer agent

January 31, 2011

A team of Yale University scientists has synthesized for the first time a chemical compound called lomaiviticin aglycon, leading to the development of a new class of molecules that appear to target and destroy cancer stem ...

Scientists Synthesize Unique Family of Anti-Cancer Compounds

February 12, 2010

(PhysOrg.com) -- Yale University scientists have streamlined the process for synthesizing a family of compounds with the potential to kill cancer and other diseased cells, and have found that they represent a unique category ...

Cutting cancer to pieces: New research on bleomycin

April 30, 2014

A variety of cancers are treated with the anti-tumor agent bleomycin, though its disease-fighting properties remain poorly understood. In a new study, lead author Basab Roy—a researcher at Arizona State University's Biodesign ...

DNA falls apart when you pull it

May 20, 2011

DNA falls apart when you pull it with a tiny force: the two strands that constitute a DNA molecule disconnect. Peter Gross of VU University Amsterdam has shown this in his PhD research project. With this research, researchers ...

Recommended for you

More efficient separation of methane and CO2

October 18, 2017

To make natural gas and biogas suitable for use, the methane has to be separated from the CO2. This involves the use of membranes, filters that stop the methane and allow the CO2 to pass through. Researchers at KU Leuven ...

A new way to harness wasted methane

October 17, 2017

Methane gas, a vast natural resource, is often disposed of through burning, but new research by scientists at MIT could make it easier to capture this gas for use as fuel or a chemical feedstock.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

5 / 5 (2) May 13, 2014
It "inhibits the growth of cultured human cancer cells at nanomolar–picomolar concentrations" being citotoxic, cleaving the DNA, of all cells, not only cancer cells, so that it remains very dangerous, like other methods, radiations and chemotherapies.
It is not a fundamental new method killing only cancer with no side effects.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.